Biopharmaceutical Third Party Logistics Market size was valued at US$ 3.33 Mn in 2022 and the total revenue is expected to grow at 5.7% through 2023 to 2029, reaching nearly US$ 4.91 Mn in the forecast period. The report has covered the market trends from 2015 to forecast the market through 2029. 2022 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2022 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.To know about the Research Methodology :- Request Free Sample Report
Biopharmaceutical Third Party Logistics Market Overview:
Biopharmaceutical Third Party Logistics is a service that offers import and export of biopharmaceutical ingredients by the pharmaceutical companies by the involvement of third-party logistics. The various functions of third-party logistics are inventory management, warehousing, and fulfillment to a third-party business authority. This process involves on the contract basis between two business operations.Biopharmaceutical Third Party Logistics Market Dynamics:
The Biopharmaceutical Third Party Logistics Market is predictable to grow with a CAGR of 5.7% during the forecast period. The growth of the market is attributed to the building of a strong network in sales with new launches around the world. Moreover, the launching of biosimilar drugs with growing chronic diseases is likely to fuel the market growth in the forecast period. Biosimilar drugs are economic and due to this factor, they are creating dominance in the market. Technological innovation in warehousing like temperature management, mobile cloud solutions, data mining, real-time monitoring, and warehouse robotics is the key reason to boost the market growth. Further, these advancements are innovated to decrease human errors, reduce damages and complexity during transportation, and maintain the quality of goods like factory-made. Further, warehousing robotics is widely preferred as it reduces the labor cost while increasing warehouse throughput. This factor is increasing the adoption of robotics in warehousing due to reducing operational costs. In 2019, Amazon manufactured 100,000 robotic systems together with 800 Pegasus and Xanthus robotics systems to fulfill around 25 centers around the US. Robotics monitoring is greatly influencing the market as pharmaceutical ingredients are temperature sensitive and require continuous monitoring during transit. Moreover, companies like DHL launched a new Android and IOS app named LifeTrack which helps in monitoring the cold chain tracking platform for healthcare and pharmaceutical ingredient shipment. The app has the function to send the alarm to the shipper during the complexity. And this factor is likely to boost the Biopharmaceutical Third Party Logistics Market during the forecast period.Biopharmaceutical Third Party Logistics Market Segment Analysis:
Non-cold chain is dominating the Supply Chain segment of Biopharmaceutical Third Party Logistics Market: The non-cold chain segment is gaining more attention as compared to the cold chain segment and has accounted for the largest revenue share of 81.3% in 2020 in the Biopharmaceutical Third Party Logistics Market. The factors attributing to the growth of the market are the large-scale distribution of medicines and vaccines, high visibility, low-cost optimization, higher returns with lower risk, and these factors also help in building a strong logistic network. Further, the non-cold chain supply chain does not require continuous monitoring of temperatures like biologics and this factor is likely to fuel the growth of the market. Also, the non-cold supply chain is the most preferred mode of transit. The Cold Chain segment is growing at a significant pace in the forecast period with a CAGR of 8.9%. Biologics are greatly influencing the cold chain segment as they have gained more attention in the market. Further, the cold chain supply chain is also used for the transportation of blood products, marker testing, cellular therapies, organ transportation, vaccines, and regenerative medicines. The warehousing and Storage segment is considered to supplement the growth of the Global Biopharmaceutical Third Party Logistics Market. The warehousing and storage segment is dominating the Biopharmaceutical Third Party Logistics Market and accounted for 47.2% in 2020. The warehousing and storage segment is greatly influenced by the pharmaceutical and healthcare industries. To reduce the overall cost of end-product life science companies binding with third party logistics. Moreover, due to excess demand, the transit companies have increased the value-added services like warehousing and packaging to reduce the complexity and rush. Further, the companies have installed the barcode scanners and robots for the pic and drop facility for loading and unloading of the products. The packaging facility is the main department of warehousing the storage segment as it requires high-quality containers that are damage resistant with waterproof coating as per the regulatory standards. And these factors are further fueling the demand of the warehouse and storage segment of the Global Biopharmaceutical Third Party Logistics Market.Biopharmaceutical Third Party Logistics Market Regional Insights:
North America is dominating the global biopharmaceutical third party logistics market, with the largest market share of 43.5% in the forecast period. The growth is dominated by the increasing import and export of pharmaceutical ingredients, drugs, biologics, vaccines, and other. Furthermore, the investment in the healthcare sector by the government and the private organization together with technological advancement in the transport industry are supplementing the growth of the market in favorable aspects. Asia Pacific has estimated a substantial market share of USD 18200 million in 2020 and is likely to grow with a CAGR of 8.1% during the forecast period. The occurrence of chronic diseases like diabetes, obesity, cardiovascular diseases are grabbing more attention in the region hence this factor is creating more demand for medicine and drugs in a growing population. In addition, high technologies and advanced services with the growing economic condition of the region are the factors likely to supplement the growth of the market during the forecast period. The objective of the report is to present a comprehensive analysis of the Global Biopharmaceutical Third Party Logistics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Biopharmaceutical Third Party Logistics Market dynamics, structure by analyzing the market segments and project the Global Biopharmaceutical Third Party Logistics Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Biopharmaceutical Third Party Logistics Market make the report investor’s guide.Biopharmaceutical Third Party Logistics Market Scope: Inquire before buying
Biopharmaceutical Third Party Logistics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 3.33 Mn. Forecast Period 2023 to 2029 CAGR: 5.7% Market Size in 2029: US $ 4.91 Mn. Segments Covered: by Specimen • Cold Chain • Non-cold Chain by Service Type • Air Freight • Sea Freight • Overland • Warehousing and Storage • Others Biopharmaceutical Third Party Logistics Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Biopharmaceutical Third Party Logistics Market Key Player
• FedEx. • DHL International GmbH • SF Express • United Parcel Service of America, Inc. • AmerisourceBergen Corporation • DB Schenker • KUEHNE + NAGEL • Kerry Logistics Network Limited • Agility • McKesson Corporation • Nippon Express • C.H. Robinson Worldwide • Sinotrans • CEVA Logistics Frequently Asked Questions: 1. Which region has the largest share in Global Biopharmaceutical Third Party Logistics Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Biopharmaceutical Third Party Logistics Market? Ans: The Global Biopharmaceutical Third Party Logistics Market is growing at a CAGR of 5.7% during forecasting period 2023-2029. 3. What is scope of the Global Biopharmaceutical Third Party Logistics Market report? Ans: Global Biopharmaceutical Third Party Logistics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Biopharmaceutical Third Party Logistics Market? Ans: The important key players in the Global Biopharmaceutical Third Party Logistics Market are - FedEx.,DHL International GmbH,SF Express,United Parcel Service of America, Inc.,AmerisourceBergen Corporation,DB Schenker,KUEHNE + NAGEL,Kerry Logistics Network Limited,Agility,McKesson Corporation,Nippon Express,C.H. Robinson Worldwide,Sinotrans,CEVA Logistics 5. What is the study period of this Market? Ans: The Global Biopharmaceutical Third Party Logistics Market is studied from 2022 to 2029.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Biopharmaceutical Third Party Logistics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Biopharmaceutical Third Party Logistics Market 3.4. Geographical Snapshot of the Biopharmaceutical Third Party Logistics Market, By Manufacturer share 4. Global Biopharmaceutical Third Party Logistics Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Biopharmaceutical Third Party Logistics Market 5. Supply Side and Demand Side Indicators 6. Global Biopharmaceutical Third Party Logistics Market Analysis and Forecast, 2022-2029 6.1. Global Biopharmaceutical Third Party Logistics Market Size & Y-o-Y Growth Analysis. 7. Global Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Specimen, 2022-2029 7.1.1. Cold Chain 7.1.2. Non-cold Chain 7.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 7.2.1. Transportation 7.2.1.1. Air Freight 7.2.1.2. Sea Freight 7.2.1.3. Overland 7.2.2. Warehousing and Storage 7.2.3. Others 8. Global Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Specimen, 2022-2029 9.1.1. Cold Chain 9.1.2. Non-cold Chain 9.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 9.2.1. Transportation 9.2.1.1. Air Freight 9.2.1.2. Sea Freight 9.2.1.3. Overland 9.2.2. Warehousing and Storage 9.2.3. Others 10. North America Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 12. Canada Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-27 12.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 13. Mexico Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 14. Europe Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 15. Europe Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 17. France Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 18. Germany Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 19. Italy Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 20. Spain Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 21. Sweden Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 22. CIS Countries Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 23. Rest of Europe Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 24. Asia Pacific Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 25. Asia Pacific Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 27. India Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 28. Japan Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 29. South Korea Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 30. Australia Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 31. ASEAN Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 32. Rest of Asia Pacific Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 33. Middle East Africa Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 34. Middle East Africa Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 36. GCC Countries Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 38. Nigeria Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 39. Rest of ME&A Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 40. South America Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 41. South America Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 43. Argentina Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 44. Rest of South America Biopharmaceutical Third Party Logistics Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Supply Chain, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Service Type, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Biopharmaceutical Third Party Logistics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. DSV 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. FedEx. 45.3.3. DHL International GmbH 45.3.4. SF Express 45.3.5. United Parcel Service of America, Inc. 45.3.6. AmerisourceBergen Corporation 45.3.7. DB Schenker 45.3.8. KUEHNE + NAGEL 45.3.9. Kerry Logistics Network Limited 45.3.10. Agility 45.3.11. McKesson Corporation 45.3.12. Nippon Express 45.3.13. C.H. Robinson Worldwide 45.3.14. Sinotrans 45.3.15. CEVA Logistics 46. Primary Key Insights